Quick Answer
Aldeyra Therapeutics, Inc. reported Common Stock Shares Outstanding of 60.16 million shares for the year ending 2025.
- Aldeyra Therapeutics, Inc. showed an increase of +0.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Aldeyra Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), Aldeyra Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 981.0%.
- Historical annual values: Fiscal year 2025: 60.16 million shares | Fiscal year 2024: 59.65 million shares | Fiscal year 2023: 59.20 million shares | Fiscal year 2022: 58.56 million shares | Fiscal year 2021: 58.08 million shares | Fiscal year 2020: 38.67 million shares | Fiscal year 2019: 28.66 million shares | Fiscal year 2018: 26.24 million shares | Fiscal year 2017: 19.14 million shares | Fiscal year 2016: 12.58 million shares | Fiscal year 2015: 9.71 million shares | Fiscal year 2014: 5.57 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: